| KAI Pharmaceuticals Announces Initiation of Phase 1b Study of KAI-4169 for the ... - Business Wire (press release) |
|
|
Business Wire (press release)Secondary hyperparathyroidism develops early in chronic kidney disease (CKD) and worsens as renal function declines and progresses to end-stage renal ... read more |